13 completed, 5 terminated. 18 Phase 3, 2 Phase 2.
By phase and status
Follow perampanel: new trials by email Literature Review of perampanel trials Research Report on perampanel
Trials (filtered) newest first · largest first
All 18 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Perampanel in Focal Status Epilepticus Perampanel, Placebo - Epilepticus; Status, Focal Motor | Phase 3 | Terminated | 1 | 2022-11-02 | 2023-12-14 |
Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study) E2007 - Partial Onset Seizures | Phase 3 | Completed | 91 | 2017-06-28 | 2021-08-05 |
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome Placebo, Perampanel - Lennox-Gastaut Syndrome (LGS) | Phase 3 | Terminated | 101 | 2016-12-13 | 2022-03-09 |
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures Perampanel - Partial-Onset or Primary Generalized Tonic-Clonic Seizures | Phase 3 | Completed | 180 | 2016-11-16 | 2022-10-28 |
An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects Perampanel - Epilepsy | Phase 3 | Completed | 7 | 2015-05-12 | 2018-07-02 |
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures Perampanel, Placebo - Partial-onset Seizures | Phase 3 | Completed | 940 | 2012-05-15 | 2021-07-29 |
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures Perampanel, Placebo comparator - Seizure Disorder Generalized Tonic Clonic | Phase 3 | Completed | 163 | 2011-09-01 | 2017-08-28 |
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures perampanel - Epilepsy | Phase 3 | Completed | 1218 | 2008-10-01 | 2016-03-14 |
Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures perampanel, Placebo - Refractory Partial Seizures | Phase 3 | Completed | 712 | 2008-08-01 | 2016-01-21 |
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures E2007 (perampanel), Placebo - Refractory Partial Seizures | Phase 3 | Completed | 389 | 2008-05-01 | 2014-07-11 |
Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures E2007 (perampanel), Placebo - Refractory Partial Seizures | Phase 3 | Completed | 390 | 2008-04-30 | 2020-01-10 |
Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN) E2007 - Neuralgia | Phase 2 / Phase 3 | Completed | 262 | 2008-01-01 | 2016-01-21 |
Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations Perampanel - Parkinson's Disease | Phase 3 | Terminated | 328 | 2007-07-01 | 2016-01-21 |
An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy Placebo, E2007 (2 mg), E2007 (4 mg) - Diabetic Neuropathy | Phase 2 / Phase 3 | Completed | 352 | 2007-06-01 | 2014-07-11 |
Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations Placebo, E2007 - Parkinson's Disease | Phase 3 | Terminated | 723 | 2006-11-01 | 2014-07-11 |
A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations E2007 - Parkinson's Disease | Phase 3 | Terminated | 997 | 2006-10-01 | 2014-07-11 |
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations 2 mg perampanel, 4 mg perampanel, placebo comparator - Parkinson's Disease | Phase 3 | Completed | 752 | 2006-08-01 | 2013-05-20 |
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations E2007 - Parkinson's Disease | Phase 3 | Completed | 702 | 2006-02-01 | 2015-11-03 |
Conditions studied
Parkinson Disease (5) · Epilepsy (4) · Seizures (4) · Diabetic Neuropathies (1) · Lennox Gastaut Syndrome (1) · Neuralgia (1)
Sponsors
Eisai Inc. (11) · Eisai Co., Ltd. (3) · Eisai Limited (3) · Assistance Publique - Hôpitaux de Paris (1)
Countries
United States (8) · France (7) · South Korea (6) · Belgium (5) · Czechia (5) · Germany (5) · Italy (5) · Japan (5) · Australia (4) · Canada (4) · Hungary (4) · India (4) · Poland (4) · Spain (4) · Austria (3)
Top investigators
David Squillacote, M.D. (6) · Alessia Nicotra, MD, PhD, DIC (1) · Antonio Laurenza, M. D. (1) · Antonio Laurenza, M.D. (1) · David Squillacote, MD (1) · Francesco Bibbiani (1) · Michelle Gee, PhD. (1) · Vincent Navarro, DDS,PhD (1)
Results publications
PMID 25823975, PMID 35305920, PMID 37059702, PMID 23663001, PMID 25878175, PMID 22517103, PMID 22843280, PMID 22905857, PMID 24867391, PMID 26296511, PMID 29250772, PMID 29574701, PMID 31912493, PMID 33825230, PMID 33839450, PMID 34657389, PMID 36106379
NIH funding
2014 (2), 2005 (1), 2019 (1)